-
President Trump is reportedly considering an enforcement bid connected marijuana reclassification.
-
The bid could travel arsenic aboriginal arsenic Monday.
-
10 stocks we similar amended than Tilray Brands ›
Shares of Tilray Brands (NASDAQ: TLRY) surged 65% this past week, according to information provided by S&P Global Market Intelligence. Investors are hopeful that the Trump medication volition determination to lessen costly regulations connected the beleaguered cannabis industry.
President Donald Trump is reportedly contemplating a reclassification of marijuana from a Schedule I cause to a Schedule III drug, according to The Washington Post. A determination could travel arsenic soon arsenic Monday, Dec. 15.
The U.S. Drug Enforcement Administration (DEA) defines Schedule I drugs arsenic "drugs with nary presently accepted aesculapian usage and a precocious imaginable for abuse." Examples see ecstasy and heroin. Schedule III drugs, successful contrast, person "moderate to debased imaginable for carnal and intelligence dependence." Examples see Tylenol with codeine and testosterone.
A rescheduling of marijuana could marque it easier for cannabis companies to entree banking and different accepted fiscal services. It could besides let marijuana producers to assertion national taxation deductions for a big of accepted concern expenses that they presently cannot deduct. All of which would apt assistance boost after-tax profits for Tilray and different cannabis suppliers.
Before you bargain banal successful Tilray Brands, see this:
The Motley Fool Stock Advisor expert squad conscionable identified what they judge are the 10 champion stocks for investors to bargain now… and Tilray Brands wasn’t 1 of them. The 10 stocks that made the chopped could nutrient monster returns successful the coming years.
Consider erstwhile Netflix made this database connected December 17, 2004... if you invested $1,000 astatine the clip of our recommendation, you’d person $513,353!* Or erstwhile Nvidia made this database connected April 15, 2005... if you invested $1,000 astatine the clip of our recommendation, you’d person $1,072,908!*
Now, it’s worthy noting Stock Advisor’s full mean instrumentality is 965% — a market-crushing outperformance compared to 193% for the S&P 500. Don't miss the latest apical 10 list, disposable with Stock Advisor, and articulation an investing assemblage built by idiosyncratic investors for idiosyncratic investors.
See the 10 stocks »
*Stock Advisor returns arsenic of December 8, 2025
Joe Tenebruso has nary presumption successful immoderate of the stocks mentioned. The Motley Fool recommends Tilray Brands. The Motley Fool has a disclosure policy.
Why Tilray Stock Soared This Week was primitively published by The Motley Fool

1 day ago
12




English (CA) ·
English (US) ·
Spanish (MX) ·